Synopsis: Fiem Industries, Nirlon, Force Motors, Subros, and Lemon Tree Hotels exhibit strong financial health with a Piotroski score of 9 and attractive valuations, as reflected by PEG ratios below 1. Five stocks are highlighted here based on a combination of strong...
SYNOPSIS: Goldman Sachs India holds 49 stocks worth ₹9,331 crore, maintaining consistent long-term holdings in JK Lakshmi Cement, Zensar Technologies and Spandana Sphoorty over five years. Goldman Sachs is a global financial powerhouse known for its leadership in...
Synopsis: Lifestyle diseases are increasing fast, with over 589 million diabetes cases worldwide and nearly 90 million in India. As stress, unhealthy food, and less activity become common, more people need long-term medicines, helping the pharma market grow past 1.6...
Synopsis: SME IPO stocks are capped at 90% to control volatility, prevent price manipulation, protect retail investors, and ensure fair price discovery in a low-liquidity and high-risk market environment. Small and Medium Enterprises (SME) Initial Public Offerings...
SYNOPSIS: Silver prices hit record highs globally and in India, doubling investor Vijay Kedia’s silver ETF returns. Strong industrial demand, supply deficits, and rate-cut expectations fuel the rally, even as gold trends steady to slightly lower. Silver prices surged...
Synopsis: Pets.com rose to fame with its sock puppet mascot, Super Bowl ad, and Amazon backing during the Dot-Com boom, only to collapse in less than a year, wiping out billions in market value. In the late 1990s, the internet promised to transform every aspect of...
Synopsis: India’s diagnostic services sector is set to grow at a 12% CAGR, reaching $15-16 billion by FY30, driven by rising healthcare demand and led by players like Thyrocare, Krsnaa, Metropolis, Dr Lal PathLabs, and Vijaya Diagnostic. India’s diagnostic services...
Synopsis: Rubicon Research has emerged as one of the fastest-growing pharma companies, driven by an 81 percent revenue CAGR, strong US-focused portfolio, consistent product approvals, pricing discipline, and a spotless regulatory track record, helping it outperform...
Synopsis: Privi Speciality Chemicals is quietly building a strong global presence in aroma chemicals, backed by cost advantages, deep customer relationships, and steady capacity expansion. With growing demand from FMCG and fragrances, the company is positioning itself...
